NCT03191149 2026-04-14Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangeNational Cancer Institute (NCI)Phase 2 Recruiting46 enrolled
NCT04981509 2026-04-07Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerNational Cancer Institute (NCI)Phase 2 Recruiting65 enrolled